In this interview, Javier Puig, president of the FAC, discusses the main issues surrounding cannabis in Spain: the Supreme Court's rulings, the new political initiatives and the shift in public attitudes.
Unidos Podemos and Regulación Responsable introduce to the Spanish Senate a Non-Legislative Motion for a Comprehensive Regulation of Cannabis
The cannabis debate in Spain has now arrived to the Senate in the form of the Non-Legislative motion presented in March by Unidos Podemos in collaboration with Regulación Responsible. The NLM intends to open the medical and recreational cannabis regulation debate in order to give answers to a reality that can no longer be avoided. Keep reading.
After their triumphs in the US and Canada, cannabis extracts are also gaining popularity in Europe. While consumers really value the relaxing effect of so-called “infused edibles”, extracts that are easy to dose and simple to standardise are particularly useful for medicinal applications. Cannabinoid extraction is a science in its own right, and goes much further than what the average consumer is concerned about. The “710” culture (if you turn 710 upside down, it looks like OIL!) is finding more and more fans wherever growing cannabis is either tolerated or legal.
For the first time ever, the International Cannabis Business Conference was held a couple weeks ago in Berlin. Politicians, legal advisers, scientists, and entrepreneurs came together in order to discuss the future of the cannabis industry.
So far, Uruguay is the only country in world to legalise cannabis on a national level. Everywhere else that you can buy cannabis or hashish without much fuss, there is a catch. Sales are either simply tolerated, as in the Netherlands and Spain, or they are only permitted for medical reasons, as in some US states, Jamaica or Germany. Elsewhere, there are geographical limits to legality within the state, as in Colorado and the other eight US states plus Washington D.C., where the forbidden plant was once again legalised by popular vote for recreation, after almost 100 years of being banned.
On 9 March 2017, the long-awaited legislation on the use of cannabis as a medicine entered into force in Germany. Now that this legislation has come into effect, doctors in Germany are able to use a simple narcotic prescription to prescribe cannabis buds and products. This article examines the matter in detail.
Spanish PP politician Eduardo Van den Eynde, who suffers from cancer, has posted a letter on Facebook in which he calls for the legalisation of medical cannabis, which he himself uses to ease the effects of chemotherapy. With the response and the signs of support received, also from fellow politicians, he hopes to reopen the debate on legalisation in Spain.
As of 2017, the UK's MHRA officially recognises CBD as a medicine, on the basis of scientific evidence. To protect patients, it has established standards of safety, quality and efficacy for CBD products. Although this is a positive development for patients and the British cannabis community, the medicinal value of cannabis is not recognised.
President Rodrigo Duterte has made headlines around the world with his deadly drug policy. But despite the bloody drug war, which the "Asian Trump" kicked off in 2016, the Philippines might still approve medicinal cannabis shortly. More about this here.
In a landmark decision, the Lower House of the Dutch Parliament voted February 21st 2017, in favour of adding cannabis cultivation to its famous tolerance policy. A move that would decriminalize the supply aspect of the coffeeshops.
In a landmark decision, the Lower House of the Dutch parliament voted last week in favour of adding cannabis cultivation to its famous tolerance policy. A move that would decriminalize the supply aspect of the coffeeshops.
Since 1 January 2017, patients in Italy have been able to obtain medicinal cannabis grown and produced by the army at pharmacies nationwide. Following a year of endless debates, locally produced cannabis is now available at Italian pharmacies, although some obstacles remain.
Is cannabis regulation possible with a prohibitionist government in Spain? Cooperation between various forces in Congress, changes in public attitudes and regional regulations in place suggest we have good grounds for being hopeful.
In December 2016, the DEA dealt a fresh blow to cannabis. All cannabis extracts, including CBD, are classified under Schedule I of Controlled Substances as drugs with no medical use. The DEA again ignores scientific progress and legalisation campaigns, as well as patients who are already benefiting from the therapeutic applications of cannabis.
In Europe, there is currently a political cross-party consensus: cannabis is okay, as long as it is being used for medicinal purposes. Anything else should continue to be banned and in that context, many people are busily trying to keep the two discussions well apart from each other. None of the large right-wing parties, addiction researchers, doctors and even patient associations adopt a prohibitionist stance when talking about the re-legalisation of cannabis. "This question," they always say, "Has nothing to do with the other question. The medicinal use we are talking about is to reduce the symptoms of disease; recreational use is just about getting high."
Since the use of cannabis as medication for and by patients was legalised in Germany by the taking of legal action, people in possession of a “Certificate of Exemption for Self-Treatment with Medicinal Hemp Buds whilst under Medical Supervision” shouldn't actually need to worry any more about having trouble with the law due to this otherwise prohibited plant. However...
The international movement to legalise and regulate cannabis has achieved such staggering success in recent years that the cause has now become mainstream, and an increasingly significant political issue in dozens of countries worldwide. After the successes of last year, what does 2017 hold for the cannabis industry?
The Global Commission on Drug Policy, comprised of 23 renowned key political and intellectual figures, has presented its 2016 report, advocating the worldwide decriminalisation of all drugs and recommending the abolition of criminal and civil penalties, which continue to be in force for the use and possession of drugs in much of the world.
On the 30th of November 2016, an International Conference on Medical Cannabis was held for the first time in the European Parliament. Politicians gathered with a range of patients, activists, campaigners, entrepreneurs and scientists from the European cannabis community to discuss the future of the industry.